Large Copy-Number Variations in Patients With Statin-Associated Myopathy Affecting Statin Myopathy-Related Loci
Authors:
- V. StráneckýVSV. Stránecký
- M. NeřoldováMNM. Neřoldová
- K. HodaňováKHK. Hodaňová
- H. HartmannováHHH. Hartmannová
- L. PiherováLPL. Piherová
- P. ZemánkováPZP. Zemánková
- A. PřistoupilováAPA. Přistoupilová
- M. VrablíkMVM. Vrablík
- M. AdámkováMAM. Adámková
- S. KmochSKS. Kmoch
- M. JirsaMJM. Jirsa
- 18 December 2016
- journal article
- Published by Institute of Physiology of the Czech Academy of Sciences in Physiological Research
- Vol. 65 (6) , 1005-1011
Abstract
Some patients are susceptible to statin-associated myopathy (SAM) either because of genetic variations affecting statin uptake and metabolism, or because they predispose their carriers to muscular diseases. Among the frequent variants examined using the genome-wide association study approach, SLCO1B1 c.521T>C represents the only validated predictor of SAM in patients treated with high-dose simvastatin. Our aim was to ascertain the overall contribution of large copy-number variations (CNVs) to SAM diagnosed in 86 patients. CNVs were detected by whole genome genotyping using Illumina HumanOmni2.5 Exome BeadChips. Exome sequence data were used for validation of CNVs in SAM-related loci. In addition, we performed a specific search for CNVs in the SLCO1B region detected recently in Rotor syndrome subjects. Rare deletions possibly contributing to genetic predisposition to SAM were found in two patients: one removed EYS associated previously with SAM, the other was present in LARGE associated with congenital muscular dystrophy. Another two patients carried deletions in CYP2C19, which may predispose to clopidogrel-statin interactions. We found no common large CNVs potentially associated with SAM and no CNVs in the SLCO1B locus. Our findings suggest that large CNVs do not play a substantial role in the etiology of SAM.Keywords
This publication has 27 references indexed in Scilit:
- Mutations in PNPLA6 are linked to photoreceptor degeneration and various forms of childhood blindnessNature Communications, 2015
- Recessive Inheritance of Population-Specific Intronic LINE-1 Insertion Causes a Rotor Syndrome PhenotypeHuman Mutation, 2014
- Statins and the neuromuscular system: a neurologist's perspectiveEuropean Journal of Neurology, 2014
- Pharmacogenomics of statin therapyCurrent Opinion in Lipidology, 2014
- Statin-induced muscle toxicity and susceptibility to malignant hyperthermia and other muscle diseases: a population-based case-control study including 1st and 2nd degree relativesEuropean Journal of Clinical Pharmacology, 2014
- Approach to Clinical and Genetic Characterization of Statin-Induced Myopathy2014
- Impact of Genetic Polymorphisms in CYP2C9 and CYP2C19 on the Pharmacokinetics of Clinically Used DrugsDrug Metabolism and Pharmacokinetics, 2013
- Association of common variants in the human eyes shut ortholog (EYS) with statin‐induced myopathy: Evidence for additional functions of EYSMuscle & Nerve, 2011
- Congenital muscular dystrophy type 1D (MDC1D) due to a large intragenic insertion/deletion, involving intron 10 of the LARGE geneEuropean Journal of Human Genetics, 2011
- The genetics of statin-induced myopathyAtherosclerosis, 2010